CARD11 gain of function upregulates BCL2A1 and promotes resistance to targeted therapies combination in B-cell lymphoma Blood
A human genome editing-based MLL::AF4 B-cell ALL model recapitulates key cellular and molecular leukemogenic features Blood
Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes LEUKEMIA RES
Formation of an invasion-permissive matrix requires TGFβ/SNAIL1-regulated alternative splicing of fibronectin Breast Cancer Res
NOX2 control over energy metabolism plays a role in acute myeloid leukaemia prognosis and survival FREE RADICAL BIO MED
Endothelial activation and damage as a common pathological substrate in different pathologies and cell therapy complications FRONT MED-LAUSANNE